Quantinuum’s $1.68 Billion IPO Opens Hot and Closes Flat

Quantinuum’s quantum computing IPO raised $1.68 billion on June 4, priced at $60 a share after investor demand drove the offering well above its original $45-to-$50 marketing range. It opened on the Nasdaq at $68, hit a session high of $71.35, then closed at $60.38, barely above where it priced the night before.

The S-1 prospectus, the registration statement Quantinuum filed with the U.S. Securities and Exchange Commission (SEC) before its debut, explains the muted close. First-quarter 2026 revenue came in at $5.2 million, down 73% from $19.1 million in the same period a year earlier, while the net loss for those three months reached $136.6 million.

From $45 to $60 in Nine Days

Quantinuum originally planned to offer 21 million Class A shares at $45 to $50 each. Institutional demand pushed the company to expand the deal. A revised price range of $53 to $55 followed, and on the evening of June 3 the company set final terms at $60 for 28 million shares. J.P. Morgan and Morgan Stanley served as joint lead underwriters, with Jefferies and Evercore ISI as additional active book-runners and BofA Securities and UBS among the broader syndicate.

The company had last raised private capital in September 2025, a $600 million round that valued it at $10 billion. The $60 IPO price implied a roughly 56% step-up from that private figure nine months later. The underwriters also hold a 30-day option to purchase up to 4.2 million additional shares at $60 to cover over-allotments; exercised in full, total proceeds rise to approximately $1.93 billion.

Pre-market indications on the morning of June 4 moved sharply. Early signals hovered near $61.50, then buying pressure lifted them as high as $78 before settling at $68 by the opening bell. The stock peaked at $71.35 and retreated through the session. NVentures, the venture capital arm of chipmaker Nvidia, joined the September 2025 private round alongside Serendipity Capital and Quanta Computer. QED Investors, a fintech-focused venture firm that also joined that round, opted not to sell any shares in the IPO.

• $45 to $50: initial marketing range for 21 million shares
• $60: final IPO price, 28 million Class A shares placed
• $68: opening trade on June 4, a 13.3% premium over the offer price
• $60.38: closing price on day one, 63 cents above the IPO price

The Revenue Case for a $15.6 Billion Company

Revenue Heading the Wrong Direction

Quantinuum’s full-year 2025 revenue of $30.9 million, up from $23.0 million in 2024, earned a $15.6 billion valuation at the offer price. That ratio is roughly 500 times annual sales. The highest-growth software companies can sometimes trade at 20 to 30 times forward revenue when their growth compounds quickly and margins are improving. Quantinuum’s revenue grew modestly over two years and its margins are negative.

First-quarter 2026 revenue fell to $5.2 million from $19.1 million in Q1 2025, a 73% year-over-year drop. The company attributes the decline partly to a large sales-type lease transaction in Q1 2025 that did not recur. New bookings, the measure of customer contract commitments, came in at $1.3 million for the quarter, below the $1.9 million in Q1 2025. Quantinuum’s registration statement filed with the Securities and Exchange Commission shows full-year 2025 bookings at $79.3 million, though the quarterly pattern is uneven. The 2025 revenue split shows approximately $16.5 million from hardware arrangements and $14.8 million from cloud platform access, research, and support services, a mix that has not settled into a single dominant model.

R&D Spending Against Sales

Research and development consumed $165.4 million in 2025, more than five times the company’s full-year revenue. The net loss for the same period hit $192.6 million, nearly six times the top line. In Q1 2026, the company posted a $136.6 million net loss on $5.2 million of revenue.

Cash on hand as of March 31, 2026 stood at $677 million before the IPO proceeds. Rajeeb Hazra, Quantinuum’s chief executive, told CNBC on June 4 that customers are “using our commercially available hardware and software, our full stack, to get started with their quantum journey.” The prospectus shows those customers paying at a current quarterly revenue scale of $5.2 million.

A Single Customer Holds 60% of 2025 Sales

A single institution, RIKEN, Japan’s national research institute, accounted for 60% of Quantinuum’s 2025 revenue, per a risk disclosure in the S-1. On $30.9 million of annual sales, that works out to roughly $18.5 million from one buyer. RIKEN operates at the center of Japan’s quantum research ecosystem; RIKEN’s quantum computing partnerships across Asia, including a 256-qubit superconducting system built with Fujitsu, reflect the institute’s central role in the field. A shift in RIKEN’s research priorities or government funding cycle could reshape Quantinuum’s revenue substantially in any given year.

Honeywell International sits on both sides of the ledger. Honeywell created Quantinuum in 2021 by merging its own quantum computing division with Cambridge Quantum, a U.K.-based quantum software firm. The company maintains a dual-class share structure: Honeywell and other pre-IPO holders retain Class B shares, giving them about 49.1% of combined voting power, while Class A shares sold to the public collectively represent approximately 11.3% of total voting power even if underwriters exercise their full option, per the S-1/A filed with the SEC. Honeywell also appears in the prospectus as a paying customer for chemistry applications. The S-1 separately discloses a National Security Agreement with the U.S. government restricting the company from hiring foreign nationals for certain roles and requiring government non-objection before specific executive appointments can be made.

The broader named customer list covers JPMorgan Chase in financial services, Amgen in pharmaceuticals, and Mitsui & Co. in cybersecurity, but none of those are disclosed as accounting for a RIKEN-level share of sales. Full-year 2025 bookings totaled $79.3 million against $30.9 million in recognized revenue, but Q1 2026 bookings of $1.3 million show how unevenly those contracts land. Quantum computing revenue today is a project business priced as a platform.

Against IonQ on the Same Hardware

Both Quantinuum and IonQ (NYSE: IONQ) use trapped-ion quantum computing systems, the same fundamental hardware architecture. IonQ reached public markets in 2021 via a SPAC (special purpose acquisition company, a blank-check shell used to take a private firm public through a merger). Quantinuum chose the traditional IPO route, and both now compete for capital in a sector where valuation logic is still developing.

IonQ reported $130 million in 2025 revenue, up 202% year over year, and is guiding toward $225 million to $245 million in 2026. Its market capitalization runs roughly $12.1 billion. Quantinuum enters at $15.6 billion on $30.9 million in 2025 revenue. At $130 million in revenue and $12.1 billion in market cap, IonQ trades at roughly 93 times annual sales; Quantinuum at $15.6 billion against $30.9 million trades closer to 500 times. The premium Quantinuum commands rests partly on its full-stack positioning (hardware and software from a single provider) and partly on Honeywell’s industrial backing, which implies a longer patience horizon than a standalone startup can sustain.

IonQ’s 2026 guidance of $225 to $245 million, if achieved, would mark a second consecutive year of more than 200% revenue growth. That trajectory is the benchmark Quantinuum would need to approach to justify a comparable valuation at current prices.

D-Wave Quantum (NYSE: QBTS) and Rigetti Computing (Nasdaq: RGTI) both posted extraordinary gains in 2025 before pulling back in 2026 as year-over-year comparisons hardened. Rigetti was down 10% year-to-date through early May after missing Q4 revenue estimates; D-Wave was down 9% over the same period despite an 83% GAAP gross margin. Quantinuum enters a public market that has already run this cycle once.

The Week That Made Quantum Unavoidable

Microsoft’s Claim and the Skeptics

Quantinuum’s debut landed two days after Microsoft unveiled Majorana 2, its next-generation topological quantum chip, at the Build 2026 developer conference on June 2. The chip, redesigned with the help of Microsoft’s agentic AI tools, delivers a claimed 1,000-fold improvement in qubit reliability over its predecessor and a mean qubit lifetime of 20 seconds, compared to microseconds for conventional superconducting systems. Microsoft now targets scalable, commercially useful quantum computing by 2029, cutting its earlier timeline in half.

Outside physicists were pointed. Henry Legg, a quantum physics lecturer at the University of St. Andrews, told reporters that Microsoft’s approach “doesn’t even work and never has” and that results require reproducibility before they carry scientific weight. Microsoft executives countered that they have shared data confidentially with the Defense Advanced Research Projects Agency (DARPA), which is evaluating multiple quantum architectures. IBM set the same 2029 commercial target separately and has committed to spending $10 billion on quantum development.

Government Backing, Sector Momentum

In May, the Trump administration signed letters of intent directing more than $2 billion in quantum funding to nine U.S. companies, drawing on the 2022 Chips and Science Act. Quantinuum is set to receive $100 million from that program. AI chipmaker Cerebras had popped roughly 70% on its Nasdaq debut in mid-May, setting an expectation for deep-tech listings that Quantinuum’s June 4 debut did not match.

We’re seeing capital markets recognize the long-term potential of compute infrastructure, and they see quantum as a potentially disruptive part of that. What’s a part of that you can buy early right now? Quantum.

Will Zeng, a partner at Quantonation, a VC firm focused on quantum investing, made that case after the debut, placing the IPO within the broader compute infrastructure wave that has driven data center spending over the past three years. Boston Consulting Group estimates quantum computing could add as much as $850 billion in global economic value by 2040, the long-arc argument that allows investors to price the technology beyond what near-term revenue can support. Alex Taub, principal at QED Investors, framed the firm’s September 2025 bet on a five-to-ten-year timeline: “We’re trying to chase the puck in terms of where we see fintech going, not today, but five to 10 years out.” QED did not sell its shares in the offering and has not disclosed plans for when the standard six-month lockup period expires. Infleqtion, IQM, and Pasqal all reached public markets via SPAC in the past year; Quantinuum’s traditional IPO was the largest in the sector’s history by proceeds raised, according to PitchBook data.

The offering closed formally on June 5; underwriters have 30 days from that date to exercise their option on up to 4.2 million additional shares at $60.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Investing in initial public offerings and early-stage technology companies involves significant risk, including the potential loss of principal. Figures cited are accurate as of publication; readers should consult a qualified financial professional before making any investment decision.